Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Promyelocytic, Acute

Explore clinical trials studying Leukemia, Promyelocytic, Acute. Study availability and eligibility vary by location and protocol.

87 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Promyelocytic, Acute trial results

Completed

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

NCT01404949

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Northwestern University Evanston, Illinois, United States
  • National Heart, Lung, and Blood Institute (NIH) Bethesda, Maryland, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details
Completed

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00105001

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
View Trial Details
Completed

A Phase I, Two-part Study to Determine the Recommended Dose and Evaluate the Safety and Tolerability of a Novel Oral Arsenic Trioxide Formulation (ORH-2014) in Subjects With Advanced Hematological Disorders

NCT03048344

Conditions
Advanced Hematological Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Weill Cornell Medical College New York, United States
  • Vanderbilt University Nashville, Tennessee, United States
  • MD Anderson Houston, Texas, United States
View Trial Details

Related conditions